Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Over the long term, broad indices tend to outperform many active strategies due to lower costs and market-wide diversification.
27,915 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
A tidal wave of data centers is pushing power demands higher. Five dividend stocks are quietly funding the grid expan...
A New York couple moves to a small Italian village after purchasing a $13,000 property, highlighting the financial tr...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...
Elite MBA salaries stay sky-high, with three-year post-graduation medians near $260,000 at top schools. The numbers r...
A fresh study links childhood money beliefs to adult investing behavior, prompting a shift toward mindset-first finan...
Palo Alto Networks fell sharply after reporting a solid Q2 on earnings but guiding Q3 profits below expectations. The...
On Feb 26, The Trade Desk faced a sharp move as management guided softer revenue growth and rising margins strained b...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
Bitcoin traders faced a fresh test as a leading corporate BTC holder dumped 3,588 coins for $216 million. The move co...
PepsiCo trims snack prices in North America to spur demand, but the pause in regional growth keeps investors focused ...
Analysts say the doom loop helps explain why the global economy is growing bleaker in 2026. High borrowing costs, wea...